185 related articles for article (PubMed ID: 33600260)
1. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J
DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260
[TBL] [Abstract][Full Text] [Related]
2. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
[No Abstract] [Full Text] [Related]
3. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
[No Abstract] [Full Text] [Related]
4. Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.
Li H; Ma H; Ma J; Qin F; Fan S; Kong S; Zhao S; Ma J
J Cell Mol Med; 2024 Jun; 28(11):e18473. PubMed ID: 38847477
[TBL] [Abstract][Full Text] [Related]
5. Identifying the mRNAs associated with Bladder cancer recurrence.
Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
[TBL] [Abstract][Full Text] [Related]
6. Differentially Expressed Genes in Matched Normal, Cancer, and Lymph Node Metastases Predict Clinical Outcomes in Patients With Breast Cancer.
Kim GE; Kim NI; Lee JS; Park MH; Kang K
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):111-122. PubMed ID: 32044879
[TBL] [Abstract][Full Text] [Related]
7. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic identification of prognostic indicators in bladder cancer.
Quan J; Zhang W; Yu C; Bai Y; Cui J; Lv J; Zhang Q
Biomark Med; 2020 Sep; 14(13):1243-1254. PubMed ID: 32749145
[No Abstract] [Full Text] [Related]
9. Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target.
Yamada Y; Kato M; Arai T; Sanada H; Uchida A; Misono S; Sakamoto S; Komiya A; Ichikawa T; Seki N
Mol Oncol; 2019 Sep; 13(9):1898-1912. PubMed ID: 31199049
[TBL] [Abstract][Full Text] [Related]
10. A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
Tang Y; Hu Y; Wang J; Zeng Z
Int Immunopharmacol; 2020 Oct; 87():106851. PubMed ID: 32763782
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.
Yeh HC; Huang CN; Li CC; Chang LL; Lin HH; Ke HL; Huang AM; Liang PI; Li CF; Wu WJ
World J Urol; 2016 Jun; 34(6):835-46. PubMed ID: 26433386
[TBL] [Abstract][Full Text] [Related]
13. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
Tang K; Wang C; Chen Z; Xu H; Ye Z
Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
[TBL] [Abstract][Full Text] [Related]
15. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
[TBL] [Abstract][Full Text] [Related]
16. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
17. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis and prognostic potential of RAC3 in bladder tumor.
Wang S; Wei Z; Shu H; Xu Y; Fan Z; Shuang S; Li P; Lu P; Ye C
Int Urol Nephrol; 2024 Feb; 56(2):475-482. PubMed ID: 37728806
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.
Zhang S; Li J; Zhou G; Mu D; Yan J; Xing J; Yao Z; Sheng H; Li D; Lv C; Sun B; Hong Q; Guo H
Tumour Biol; 2016 Apr; 37(4):5165-70. PubMed ID: 26547586
[TBL] [Abstract][Full Text] [Related]
20. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H
PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
